For men, prostate cancer remains the second most common type of cancer. Only skin cancer is more prevalent. Over the course of his lifetime, one in every seven men will develop prostate cancer and one in 39 men will die of prostate cancer. The difference in those numbers means that lots of men are surviving […]

Guest blog by: Marianne Shenouda, Pharm.D., Clinical Pharmacy Specialist, BioPlus Specialty Pharmacy Inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, are chronic inflammatory diseases of the bowel. These diseases can develop as a result of genetic or environmental factors, such as smoking, diet, or any alteration of the normal human gut flora. These factors […]

When it comes to rheumatoid arthritis, the foods one eats or avoids can actually affect the symptoms of this autoimmune disease. Dietary interventions can be a useful compliment to pharmacological treatment of rheumatoid arthritis. What it mostly comes down to are certain foods that either promote or discourage inflammation. Overall, a type of diet known […]

Guest blog by: Monica Morgan, Pharm.D., CSP As a specialty pharmacy that works with many patients during treatment for liver diseases, it’s not surprising that questions about nonalcoholic fatty liver disease (NAFLD) come up in our line of work. Although hepatitis C is our primary liver focus, both hepatitis C and NAFLD rank as the […]

The amino acid taurine has caught the attention of multiple sclerosis researchers. Amino acids are the building blocks of protein. Taurine can be found in many places throughout the body, such as the cardiovascular system where it plays an essential role in heart function, but it also shows up in the central nervous system. Taurine […]

Hepatitis C screening programs and treatment outreach tend to focus on three key populations: Baby Boomers, IV drug users, and prison populations. This is understandable, since rates of infection are notable in these high-risk groups. However, children infected with the hepatitis C virus (HCV) deserve attention, too. Of the more than 4 million people with […]

Scroll to Top